Mycobacterium tuberculosis infection
Conditions
Interventions
Cohort 1:Blood samples were collected for specific ?-IFN (T-SPOT) detection, and then EC and TB-PPD skin tests were performed on both arms. One dose of the test drug was injected intradermally into th
Cohort 2:Subjects were tested for EC on single arm skin.
Sponsors
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Eligibility
Sex/Gender
All
Age
0.5 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients aged 6 months and above (>=6 months), no gender limit; 2. Patients with normal armpit body temperature (< 37.5? from 6 months to 14 years old, < 37.3? from 15 years old and above); 3. The patient and/or guardian agree to participate in the study and sign the informed consent, and are willing and able to comply with the requirements of the clinical study protocol.
Exclusion criteria
Exclusion criteria: 1. Patients with acute infectious diseases (such as measles, whooping cough, influenza, pneumonia, etc.), acute eye conjunctivitis, acute otitis media, extensive skin diseases and allergic constitution; 2. Use PPD or similar products within 3 months before clinical trial; 3. Participated in clinical trials of other new drugs within 3 months before clinical trials; 4. The investigator considered that there were any circumstances which might affect the evaluation of the test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of millimeters (mm) in transverse and longitudinal diameters of the red halos;The number of millimeters (mm) in transverse and longitudinal diameters of indurations; | — |
Countries
China
Contacts
Public ContactMo Yi
Guangxi Center for Disease Control and Prevention
Outcome results
None listed